29 related articles for article (PubMed ID: 38726652)
1. U.S. Women with Invasive Cervical Cancer: Characteristics and Potential Barriers to Prevention.
Rosenblum HG; Gargano JW; Cleveland AA; Dahl RM; Park IU; Whitney E; Castilho JL; Sackey E; Niccolai LM; Brackney M; Debess E; Ehlers S; Bennett NM; Kurtz R; Unger ER; Markowitz LE
J Womens Health (Larchmt); 2024 May; 33(5):594-603. PubMed ID: 38608239
[No Abstract] [Full Text] [Related]
2. Primary Human Papillomavirus Test Uptake and Cervical Cancer Screening Trends in the Midwest, United States.
Ehman KM; Jenkins GD; Grimm JA; Cammack TL; Samuelson BJ; Stoll RJ; Maxson JA; MacLaughlin KL
J Prim Care Community Health; 2024; 15():21501319241251934. PubMed ID: 38726652
[TBL] [Abstract][Full Text] [Related]
3. Cancer statistics, 2024.
Siegel RL; Giaquinto AN; Jemal A
CA Cancer J Clin; 2024; 74(1):12-49. PubMed ID: 38230766
[TBL] [Abstract][Full Text] [Related]
4. Up-to-Date Breast, Cervical, and Colorectal Cancer Screening Test Use in the United States, 2021.
Sabatino SA; Thompson TD; White MC; Villarroel MA; Shapiro JA; Croswell JM; Richardson LC
Prev Chronic Dis; 2023 Oct; 20():E94. PubMed ID: 37884318
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer prevention in the United States-where we've been and where we're going: The American Cancer Society Primary HPV Screening Initiative.
Nayar R
Cancer Cytopathol; 2023 Dec; 131(12):747-750. PubMed ID: 37347982
[No Abstract] [Full Text] [Related]
6. Clinician practices, knowledge, and attitudes regarding primary human papillomavirus testing for cervical cancer screening: A mixed-methods study in Indiana.
Rodriguez NM; Brennan LP; Claure L; Balian LN; Kasting ML; Champion VL; Forman MR
Prev Med Rep; 2023 Feb; 31():102070. PubMed ID: 36471770
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening among women with comorbidities: a cross-sectional examination of disparities from the Behavioral Risk Factor Surveillance System.
Austin J; Delgado P; Gatewood A; Enmeier M; Frantz B; Greiner B; Hartwell M
J Osteopath Med; 2022 Mar; 122(7):359-365. PubMed ID: 35285219
[TBL] [Abstract][Full Text] [Related]
8. Awareness and Support of Clinician- and Patient-Collected Human Papillomavirus Testing for Cervical Cancer Screening Among Primary Care Clinicians.
MacLaughlin KL; Jacobson RM; St Sauver JL; Jenkins GD; Fan C; Finney Rutten LJ
Womens Health Rep (New Rochelle); 2022; 3(1):10-19. PubMed ID: 35136872
[No Abstract] [Full Text] [Related]
9. Assessment of US Preventive Services Task Force Guideline-Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019.
Suk R; Hong YR; Rajan SS; Xie Z; Zhu Y; Spencer JC
JAMA Netw Open; 2022 Jan; 5(1):e2143582. PubMed ID: 35040970
[TBL] [Abstract][Full Text] [Related]
10. Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.
Qin J; Shahangian S; Saraiya M; Holt H; Gagnon M; Sawaya GF
Gynecol Oncol; 2021 Nov; 163(2):378-384. PubMed ID: 34507826
[TBL] [Abstract][Full Text] [Related]
11. Assessing Physician Adherence to Guidelines for Cervical Cancer Screening and Management of Abnormal Screening Results.
Min CJ; Massad LS; Dick R; Powell MA; Kuroki LM
J Low Genit Tract Dis; 2020 Oct; 24(4):337-342. PubMed ID: 32976292
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.
Fontham ETH; Wolf AMD; Church TR; Etzioni R; Flowers CR; Herzig A; Guerra CE; Oeffinger KC; Shih YT; Walter LC; Kim JJ; Andrews KS; DeSantis CE; Fedewa SA; Manassaram-Baptiste D; Saslow D; Wender RC; Smith RA
CA Cancer J Clin; 2020 Sep; 70(5):321-346. PubMed ID: 32729638
[TBL] [Abstract][Full Text] [Related]
13. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB; Guido RS; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M;
J Low Genit Tract Dis; 2020 Apr; 24(2):102-131. PubMed ID: 32243307
[No Abstract] [Full Text] [Related]
14. Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
MacLaughlin KL; Jacobson RM; Radecki Breitkopf C; Wilson PM; Jacobson DJ; Fan C; St Sauver JL; Rutten LJF
J Womens Health (Larchmt); 2019 Feb; 28(2):244-249. PubMed ID: 30614380
[TBL] [Abstract][Full Text] [Related]
15. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.
; Curry SJ; Krist AH; Owens DK; Barry MJ; Caughey AB; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Kubik M; Landefeld CS; Mangione CM; Phipps MG; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2018 Aug; 320(7):674-686. PubMed ID: 30140884
[TBL] [Abstract][Full Text] [Related]
16. Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force.
Kim JJ; Burger EA; Regan C; Sy S
JAMA; 2018 Aug; 320(7):706-714. PubMed ID: 30140882
[TBL] [Abstract][Full Text] [Related]
17. Primary HPV testing recommendations of US providers, 2015.
Cooper CP; Saraiya M
Prev Med; 2017 Dec; 105():372-377. PubMed ID: 29056319
[TBL] [Abstract][Full Text] [Related]
18. Are smokers less likely to seek preventive healthcare measures in Italy?
Carreras G; Iannucci L; Costa G; Chellini E; Gorini G
Eur J Cancer Prev; 2018 Sep; 27(5):507-513. PubMed ID: 28379886
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
